Investor Alert

Company Close Updates

May 10, 2022, 5:18 p.m. EDT

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day

MarketWatch Automation

Shares of Regeneron Pharmaceuticals Inc. (NAS:REGN) rallied 2.55% to $615.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index (S&P:SPX) rising 0.25% to 4,001.05 and the Dow Jones Industrial Average (DOW:DJIA) falling 0.26% to 32,160.74. The stock's rise snapped a three-day losing streak. Regeneron Pharmaceuticals Inc. closed $132.33 short of its 52-week high ($747.42), which the company achieved on April 8th.

The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (NYS:JNJ) fell 0.14% to $177.09, Novartis AG ADR (NYS:NVS) rose 1.09% to $84.39, and Amgen Inc. (NAS:AMGN) rose 0.61% to $240.71. Trading volume (769,478) eclipsed its 50-day average volume of 655,931.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.